Tirzepatide is a groundbreaking treatment agent for individuals struggling type 2 diabetes. As a dual agonist, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) https://montykdam819010.wizzardsblog.com/40520916/tirzepatide-a-game-changer-for-type-2-diabetes